Firefly Neuroscience, Inc. $AIFF

What the company doesAI summary of filing

Firefly Neuroscience is an artificial intelligence company that develops and commercializes the Firefly Platform, a vertically integrated system for brain health diagnostics combining FDA-cleared hardware (the Evoke System), cloud-based analytics software, and a proprietary database of over 191,000 standardized electroencephalogram (EEG) and event-related potential (ERP) assessments. The company sells subscriptions to clinics and healthcare providers for access to the Evoke System hardware, analytics platform, and clinical reports designed to support decision-making in neurological and psychiatric conditions; the company generates recurring revenue through tiered monthly subscriptions based on clinical utilization, with additional per-scan charges for assessments exceeding monthly allotments. Firefly is revenue-generating, with the Evoke System deployed across more than 85 clinical sites in the United States as of December 31, 2025, and also engages in research collaborations and pharmaceutical partnerships that leverage its database and analytical capabilities. [10-K 2026-03-31]

Segments: Evoke System (FDA-cleared EEG/ERP hardware), Firefly Platform (cloud-based analytics and reporting), Proprietary EEG/ERP database, Pharmaceutical and research partnerships